Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Aurinia Pharmaceuticals to Release Fourth Quarter and Full Year 2019 Financial Results on March 5, 2020


Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the "Company") today announced that it will release its fourth quarter and full year 2019 financial results on Thursday, March 5, 2020, after the markets close. Aurinia's management team will host a conference call to discuss the Company's financial results and to provide a general business update.

The conference call and webcast is scheduled for March 5, 2020 at 4:30 p.m. ET / 1:30 p.m. PT. In order to participate in the conference call, please dial +1-877-407-9170 (Toll-free U.S. & Canada). An audio webcast can be accessed under "News/Events" through the "Investors" section of the Aurinia corporate website at www.auriniapharma.com. A replay of the webcast will be available on Aurinia's website.

About Aurinia

Aurinia Pharmaceuticals is a late clinical-stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations that are impacted by diseases with a high unmet medical need. The Company is currently developing an investigational drug, voclosporin, for the treatment of lupus nephritis, focal segmental glomerulosclerosis and dry eye syndrome. The Company's head office is in Victoria, British Columbia and focuses its development efforts globally. For further information, see our website at www.auriniapharma.com.


These press releases may also interest you

at 12:45
Beaverlab today announced the launch of a Kickstarter campaign for its new Excope DT1 camera. Excope DT1 is the world's lightest, portable super-telephoto camera for photos and videos. It is versatile, relieving photographers from the hassle of...

at 12:14
Anodot publishes its annual Cloud Cost Optimization Report, delivering insights from customer data and analysis of news and trends within the FinOps sector to prepare cloud users for 2024....

at 12:10
Pieris Pharmaceuticals, Inc. today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on April 22, 2024. The Company's...

at 12:05
Phenom today announced IAMPHENOM ? the human resources event for talent acquisition, talent management, CHROs, HRIS and executives ? has sold out with record-breaking registrations and is reaching maximum capacity. Waitlisting is now available. The...

at 12:00
Sony Electronics Inc. today announced a new addition to its line of car AV receivers, the XAV-AX3700. The XAV-AX3700 includes a customizable experience to fit user's personal viewing preference, while providing optimal sound. This new model includes...

at 11:40
TransAlta Corporation ("TransAlta" or the "Company") announced today that it has signed onto a voluntary water-sharing memorandum of understanding ("MOU") with over thirty other water licence holders in the Bow River Basin. Water-sharing MOUs have...



News published on and distributed by: